Ibere Pharmaceuticals Announces Closing of $138,000,000 Initial Public Offering

PHILADELPHIA, March 2, 2021 /PRNewswire/ -- Ibere Pharmaceuticals (the "Company") announced today that it closed its initial public offering of 13,800,000 units at $10.00 per unit, which included the exercise in full of the underwriter's over-allotment option to purchase 1,800,000 Units....

from PR Newswire: https://ift.tt/2NMowrv